Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inmune Bio (INMB) Cash from Operations (2018 - 2025)

Inmune Bio (INMB) has disclosed Cash from Operations for 8 consecutive years, with 2944000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations rose 73.27% to 2944000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 22582000.0 through Dec 2025, up 32.31% year-over-year, with the annual reading at 22582000.0 for FY2025, 32.31% up from the prior year.
  • Cash from Operations hit 2944000.0 in Q4 2025 for Inmune Bio, up from 5438000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 1141000.0 in Q1 2023 to a low of 11013000.0 in Q4 2024.
  • Historically, Cash from Operations has averaged 5955650.0 across 5 years, with a median of 5702000.0 in 2021.
  • Biggest five-year swings in Cash from Operations: soared 87.13% in 2023 and later tumbled 555.21% in 2024.
  • Year by year, Cash from Operations stood at 9780000.0 in 2021, then surged by 41.77% to 5695000.0 in 2022, then soared by 40.28% to 3401000.0 in 2023, then crashed by 223.82% to 11013000.0 in 2024, then surged by 73.27% to 2944000.0 in 2025.
  • Business Quant data shows Cash from Operations for INMB at 2944000.0 in Q4 2025, 5438000.0 in Q3 2025, and 7400000.0 in Q2 2025.